Benzodiazepine Use and Hip Fractures in the Elderly
Open Access
- 26 July 2004
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 164 (14) , 1567-1572
- https://doi.org/10.1001/archinte.164.14.1567
Abstract
With 71 million prescriptions dispensed in 2002, and an annual growth rate of 3%, benzodiazepines are currently the 13th leading therapeutic class of medications in the United States,1 despite well-publicized concerns about their adverse effects, which include an increased risk of hip fracture among the elderly. Because hip fractures frequently lead to disability and death among the elderly,2-5 this concern has prompted recent interventions to decrease benzodiazepine use in elderly patients.6,7This publication has 21 references indexed in Scilit:
- Pharmacoeconomic evaluation of a patient education letter aimed at reducing long-term prescribing of benzodiazepinesInternational Journal of Clinical Pharmacy, 2002
- Benzodiazepines and the Risk of Falls in Nursing Home ResidentsJournal of the American Geriatrics Society, 2000
- Costs and outcomes of hip fracture and stroke, 1984 to 1994.American Journal of Public Health, 1999
- World-wide Projections for Hip FractureOsteoporosis International, 1997
- New Evidence on Benzodiazepine Use and Falls: The Time FactorAge and Ageing, 1996
- Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-lifeArchives of internal medicine (1960), 1995
- Relationship Between the Administration of Selected Medications and Falls in Hospitalized Elderly PatientsAnnals of Pharmacotherapy, 1995
- Mortality and morbidity after hip fractures.BMJ, 1993
- Risk Factors for Falls among Elderly Persons Living in the CommunityNew England Journal of Medicine, 1988
- Psychotropic Drug Use and the Risk of Hip FractureNew England Journal of Medicine, 1987